Rabbit Recombinant Monoclonal MC1-R antibody. Suitable for IHC-P, WB and reacts with Human samples. Cited in 12 publications.
View Alternative Names
MSHR, MC1R, Melanocyte-stimulating hormone receptor, MSH-R, Melanocortin receptor 1, MC1-R
- IHC-P
Unknown
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-MC1-R antibody [EPR6530] (AB125031)
ab125031, at a 1/500 dilution, staining MC1-R in paraffin embedded Human melanoma tissue by Immunohistochemistry.
Perform heat mediated antigen retrieval with citrate buffer pH 6 before commencing with IHC staining protocol.
- WB
Unknown
Western blot - Anti-MC1-R antibody [EPR6530] (AB125031)
All lanes:
Western blot - Anti-MC1-R antibody [EPR6530] (ab125031) at 1/1000 dilution
Lane 1:
A375 cell lysate at 10 µg
Lane 2:
Human melanoma lysate at 10 µg
Secondary
All lanes:
HRP labelled goat anti rabbit at 1/2000 dilution
Predicted band size: 35 kDa
false
- OI-RD Scanning
Unknown
OI-RD Scanning - Anti-MC1-R antibody [EPR6530] (AB125031)
We have systematically measured KD (the equilibrium dissociation constant between the antibody and its antigen), of more than 840 recombinant antibodies to assess not only their individual KD values but also to see the average affinity of antibody. Based on the comparison with published literature values for mouse monoclonal antibodies, Recombinant antibodies appear to be on average 1-2 order of magnitude higher affinity.
Related conjugates and formulations (1)
-
Anti-MC1-R antibody [EPR6530] - BSA and Azide free
Reactivity data
Product details
Species reactivity
Mouse, Rat: We have preliminary internal testing data to indicate this antibody may not react with these species.
Please contact us for more information.
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
The MC1-R affects pigmentation by increasing the synthesis of eumelanin the dark pigment in the skin and hair while reducing pheomelanin the red or yellow pigment. It functions as part of a complex with other melanocortin receptors working in coordination to modulate the overall pigmentation process in response to environmental cues like ultraviolet radiation. The receptor achieves this by impacting key enzymes involved in melanin production such as tyrosinase.
Pathways
The MC1-R is part of the melanogenesis pathway a critical process for pigmentation protection against UV radiation and development. It interacts with other melanocortin receptors and is activated by melanocyte-stimulating hormones (MSH). The receptor plays a role in the cyclic adenosine monophosphate (cAMP) signaling pathway where it regulates the activity of the protein kinase A (PKA) an essential step in upregulating melanin synthesis. The cAMP pathway also links MC1-R with other related proteins such as CREB which further regulates gene expression.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (12)
Recent publications for all applications. Explore the full list and refine your search
International immunopharmacology 138:112546 PubMed38917522
2024
Applications
Unspecified application
Species
Unspecified reactive species
Marine drugs 22: PubMed38786597
2024
Applications
Unspecified application
Species
Unspecified reactive species
JCO precision oncology 8:e2300702 PubMed38662983
2024
Applications
Unspecified application
Species
Unspecified reactive species
Cancer research 83:1062-1073 PubMed36701140
2023
Applications
Unspecified application
Species
Unspecified reactive species
Postepy dermatologii i alergologii 38:461-472 PubMed34377129
2021
Applications
Unspecified application
Species
Unspecified reactive species
Annals of dermatology 32:289-297 PubMed33911756
2020
Applications
Unspecified application
Species
Unspecified reactive species
Molecular pharmaceutics 16:3904-3915 PubMed31318566
2019
Applications
Unspecified application
Species
Unspecified reactive species
Nature communications 10:877 PubMed30787281
2019
Applications
Unspecified application
Species
Unspecified reactive species
European journal of pharmacology 844:1-8 PubMed30496742
2018
Applications
Unspecified application
Species
Unspecified reactive species
ACS applied materials & interfaces 10:4379-4393 PubMed29058865
2018
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com